1.
Feltgen N, Pielen A. [Retinal vein occlusion : Epidemiology, classification and clinical
findings]. Ophthalmologe. 2015;112(7):607-18; quiz 19-20.
2.
Ip M, Hendrick A. Retinal Vein Occlusion Review. Asia Pac J Ophthalmol (Phila). 2018;7(1):40-5.
3.
Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, et al. The prevalence
of retinal vein occlusion: pooled data from population studies from the United States,
Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313-9 e1.
4.
Pulido JS, Flaxel CJ, Adelman RA, Hyman L, Folk JC, Olsen TW. Retinal Vein Occlusions
Preferred Practice Pattern((R)) Guidelines. Ophthalmology. 2016;123(1):P182-208.
5.
Huang P, Niu W, Ni Z, Wang R, Sun X. A meta-analysis of anti-vascular endothelial
growth factor remedy for macular edema secondary to central retinal vein occlusion.
PLoS One. 2013;8(12):e82454.
6.
Noma H, Funatsu H, Mimura T, Harino S, Hori S. Vitreous levels of interleukin-6 and
vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Ophthalmology. 2009;116(1):87-93.
7.
Jumper JM, Dugel PU, Chen S, Blinder KJ, Walt JG. Anti-VEGF treatment of macular edema
associated with retinal vein occlusion: patterns of use and effectiveness in clinical
practice (ECHO study report 2). Clin Ophthalmol. 2018;12:621-9.
8.
Freund KB, Korobelnik JF, Devenyi R, Framme C, Galic J, Herbert E, et al. TREAT-AND-EXTEND
REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus
Recommendations. Retina. 2015;35(8):1489-506.
9.
Park J, Lee S, Son Y. Effects of two different doses of intravitreal bevacizumab on
subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion.
Int J Ophthalmol. 2016;9(7):999-1005.
10.
Qian T, Zhao M, Xu X. Comparison between anti-VEGF therapy and corticosteroid or laser
therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis. J
Clin Pharm Ther. 2017;42(5):519-29.
11.
Du KF, Xu L, Shao L, Chen CX, Zhou JQ, Wang YX, et al. Subfoveal choroidal thickness
in retinal vein occlusion. Ophthalmology. 2013;120(12):2749-50.
12.
Tsuiki E, Suzuma K, Ueki R, Maekawa Y, Kitaoka T. Enhanced depth imaging optical coherence
tomography of the choroid in central retinal vein occlusion. Am J Ophthalmol. 2013;156(3):543-7.e1.
13.
Coban-Karatas M, Altan-Yaycioglu R, Ulas B, Sizmaz S, Canan H, Sariturk C. Choroidal
thickness measurements with optical coherence tomography in branch retinal vein occlusion.
Int J Ophthalmol. 2016;9(5):725-9.
14.
Lee EK, Han JM, Hyon JY, Yu HG. Changes in choroidal thickness after intravitreal
dexamethasone implant injection in retinal vein occlusion. Br J Ophthalmol. 2015;99(11):1543-9.
15.
Arifoglu HB, Duru N, Altunel O, Baskan B, Alabay B, Atas M. Short-term effects of
intravitreal dexamethasone implant (OZURDEX(R)) on choroidal thickness in patients
with naive branch retinal vein occlusion. Arq Bras Oftalmol. 2016;79(4):243-6.
16.
Yumusak E, Ornek K, Dikel NH. Comparison of choroidal thickness changes following
intravitreal dexamethasone, ranibizumab, and triamcinolone in eyes with retinal vein
occlusion. Eur J Ophthalmol. 2016;26(6):627-32.
17.
Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, et al. Pathogenesis
of macular edema with branch retinal vein occlusion and intraocular levels of vascular
endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140(2):256-61.
18.
Miller JW, Le Couter J, Strauss EC, Ferrara N. Vascular endothelial growth factor
a in intraocular vascular disease. Ophthalmology. 2013;120(1):106-14.
19.
Iijima H. Mechanisms of vision loss in eyes with macular edema associated with retinal
vein occlusion. Jpn J Ophthalmol. 2018;62(3):265-73.
20.
Franco-Cardenas V, Shah SU, Apap D, Joseph A, Heilweil G, Zutis K, et al. Assessment
of Ischemic Index in Retinal Vascular Diseases Using Ultra-Wide-Field Fluorescein
Angiography: Single Versus Summarized Image. Semin Ophthalmol. 2017;32(3):353-7.
21.
Yasuda S, Kachi S, Ueno S, Ushida H, Piao CH, Kondo M, et al. Electroretinograms and
level of aqueous vascular endothelial growth factor in eyes with hemicentral retinal
vein occlusion or branch retinal vein occlusion. Jpn J Ophthalmol. 2014;58(3):232-6.
22.
Flores-Moreno I, Lugo F, Duker JS, Ruiz-Moreno JM. The relationship between axial
length and choroidal thickness in eyes with high myopia. Am J Ophthalmol. 2013;155(2):314-9
e1.
23.
Woodman EC, Read SA, Collins MJ. Axial length and choroidal thickness changes accompanying
prolonged accommodation in myopes and emmetropes. Vision Res. 2012;72:34-41.
24.
Ruiz-Medrano J, Flores-Moreno I, Pena-Garcia P, Montero JA, Duker JS, Ruiz-Moreno
JM. Macular choroidal thickness profile in a healthy population measured by swept-source
optical coherence tomography. Invest Ophthalmol Vis Sci. 2014;55(6):3532-42.
25.
Fujiwara A, Shiragami C, Shirakata Y, Manabe S, Izumibata S, Shiraga F. Enhanced depth
imaging spectral-domain optical coherence tomography of subfoveal choroidal thickness
in normal Japanese eyes. Jpn J Ophthalmol. 2012;56(3):230-5.
26.
Abdolrahimzadeh S, Parisi F, Scavella V, Recupero SM. Optical Coherence Tomography
Evidence on the Correlation of Choroidal Thickness and Age with Vascularized Retinal
Layers in Normal Eyes. Retina. 2016;36(12):2329-38.
27.
Gaudreault J, Fei D, Beyer JC, Ryan A, Rangell L, Shiu V, et al. Pharmacokinetics
and retinal distribution of ranibizumab, a humanized antibody fragment directed against
VEGF-A, following intravitreal administration in rabbits. Retina. 2007;27(9):1260-6.
28.
Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, et al. Baseline
choroidal thickness as a short-term predictor of visual acuity improvement following
antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br
J Ophthalmol. 2018.
29.
Rayess N, Rahimy E, Ying GS, Bagheri N, Ho AC, Regillo CD, et al. Baseline choroidal
thickness as a predictor for response to anti-vascular endothelial growth factor therapy
in diabetic macular edema. Am J Ophthalmol. 2015;159(1):85-91.e1-3.
30.
Karkhaneh R, Nikbakht M, Bazvand F, Oskouei AK, Ghasemi H, Ghassemi F. Choroidal thickness
in idiopathic macular hole. J Curr Ophthalmol. 2017;29(1):45-9.
31.
Lu L, Xu S, He F, Liu Y, Zhang Y, Wang J, et al. Assessment of Choroidal Microstructure
and Subfoveal Thickness Change in Eyes With Different Stages of Age-Related Macular
Degeneration. Medicine (Baltimore). 2016;95(10):e2967.
32.
Chung YR, Kim JW, Kim SW, Lee K. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS
CHORIORETINOPATHY: Assessment of Haller and Sattler Layers. Retina. 2016;36(9):1652-7.
33.
Maruko I, Iida T, Sugano Y, Go S, Sekiryu T. SUBFOVEAL CHOROIDAL THICKNESS IN PAPILLITIS
TYPE OF VOGT-KOYANAGI-HARADA DISEASE AND IDIOPATHIC OPTIC NEURITIS. Retina. 2016;36(5):992-9.
34.
Eliwa TF, Hegazy OS, Mahmoud SS, Almaamon T. Choroidal Thickness Change in Patients
With Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2017;48(12):970-7.
35.
Abadia B, Sunen I, Calvo P, Bartol F, Verdes G, Ferreras A. Choroidal thickness measured
using swept-source optical coherence tomography is reduced in patients with type 2
diabetes. PLoS One. 2018;13(2):e0191977.
36.
Rewbury R, Want A, Varughese R, Chong V. Subfoveal choroidal thickness in patients
with diabetic retinopathy and diabetic macular oedema. Eye (Lond). 2016;30(12):1568-72.
37.
Kim KH, Lee DH, Lee JJ, Park SW, Byon IS, Lee JE. Regional Choroidal Thickness Changes
in Branch Retinal Vein Occlusion with Macular Edema. Ophthalmologica. 2015;234(2):109-18.
38.
Rayess N, Rahimy E, Ying GS, Pefkianaki M, Franklin J, Regillo CD, et al. Baseline
choroidal thickness as a short-term predictor of visual acuity improvement following
antivascular endothelial growth factor therapy in branch retinal vein occlusion. Br
J Ophthalmol. 2019;103(1):55-9.
39.
Hasegawa T, Kawano T, Maruko I, Koizumi H, Iida T. Clinical Findings of Eyes with
Macular Edema Associated with Branch Retinal Vein Occlusion Refractory to Ranibizumab.
Retina. 2018;38(7):1347-53.
40.
Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C. The natural course of central
retinal vein occlusion. Am J Ophthalmol. 1990;110(2):118-23.
41.
Minturn J, Brown GC. Progression of nonischemic central retinal vein obstruction to
the ischemic variant. Ophthalmology. 1986;93(9):1158-62.
42.
Maruko I, Iida T, Sugano Y, Ojima A, Sekiryu T. Subfoveal choroidal thickness in fellow
eyes of patients with central serous chorioretinopathy. Retina. 2011;31(8):1603-8.
43.
Maruko I, Iida T, Sugano Y, Furuta M, Sekiryu T. One-year choroidal thickness results
after photodynamic therapy for central serous chorioretinopathy. Retina. 2011;31(9):1921-7.